Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
2776
CALL
DELISTED
Sage Therapeutics
SAGE
| $652K | ﹤0.01% |
60,000
+30,000
| +100% | +$384K |
|
2777
Kiniksa Pharmaceuticals
KNSA
$5.97B
| $650K | ﹤0.01% |
34,839
-7,308
| -17% | -$137K |
|
2778
CALL
Rapid7
RPD
$694M
| $648K | ﹤0.01% |
15,000
-100,000
| -87% | -$4.17M |
|
2779
O-I Glass
OI
$1.09B
| $647K | ﹤0.01% |
58,124
-82,697
| -59% | -$1.12M |
|
2780
Stewart Information Services
STC
$2.09B
| $646K | ﹤0.01% |
10,412
-15,377
| -60% | -$960K |
|
2781
Hanmi Financial
HAFC
$954M
| $645K | ﹤0.01% |
38,597
-32,086
| -45% | -$500K |
|
2782
CALL
Pliant Therapeutics
PLRX
$65M
| $645K | ﹤0.01% |
+60,000
| New | +$773K |
|
2783
Reynolds Consumer Products
REYN
$5.54B
| $645K | ﹤0.01% |
23,046
-10,593
| -31% | -$302K |
|
2784
Vita Coco
COCO
$3.71B
| $644K | ﹤0.01% |
23,119
-85,335
| -79% | -$2.26M |
|
2785
International Money Express
IMXI
$367M
| $644K | ﹤0.01% |
30,893
-39,932
| -56% | -$841K |
|
2786
Blue Bird Corp
BLBD
$2.09B
| $644K | ﹤0.01% |
11,951
-32,841
| -73% | -$1.51M |
|
2787
Heritage Financial
HFWA
$1.21B
| $644K | ﹤0.01% |
35,694
-24,567
| -41% | -$441K |
|
|
ILPT
2788
Industrial Logistics Properties Trust
ILPT
$575M
| $643K | ﹤0.01% |
174,725
-80,778
| -32% | -$312K |
|
2789
iShares Micro-Cap ETF
IWC
$1.5B
| $642K | ﹤0.01% |
+5,635
| New | +$650K |
|
|
PMT
2790
PennyMac Mortgage Investment
PMT
$814M
| $642K | ﹤0.01% |
46,667
-75,858
| -62% | -$1.06M |
|
2791
Metropolitan Bank Holding Corp
MCB
$1.15B
| $641K | ﹤0.01% |
15,228
-12,708
| -45% | -$508K |
|
2792
BrightView Holdings
BV
$1.02B
| $638K | ﹤0.01% |
47,934
-24,001
| -33% | -$306K |
|
2793
TFI International
TFII
$11.3B
| $637K | ﹤0.01% |
4,390
-36,228
| -89% | -$5.11M |
|
|
SEMR
2794
DELISTED
Semrush
SEMR
| $637K | ﹤0.01% |
47,577
-144,821
| -75% | -$2.01M |
|
2795
Astrana Health
ASTH
$1.69B
| $633K | ﹤0.01% |
15,618
-24,120
| -61% | -$957K |
|
2796
Hillman Solutions
HLMN
$1.76B
| $633K | ﹤0.01% |
71,574
-104,484
| -59% | -$985K |
|
2797
Repay Holdings
RPAY
$330M
| $633K | ﹤0.01% |
59,899
-31,979
| -35% | -$327K |
|
|
ROIC
2798
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $632K | ﹤0.01% |
50,835
-65,070
| -56% | -$806K |
|
|
HBI
2799
DELISTED
Hanesbrands
HBI
| $632K | ﹤0.01% |
128,141
-241,354
| -65% | -$1.18M |
|
2800
A10 Networks
ATEN
$1.99B
| $631K | ﹤0.01% |
45,566
-35,415
| -44% | -$505K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.